TY - JOUR
T1 - Combination of chiral linkers with thiophenecarboximidamide heads to improve the selectivity of inhibitors of neuronal nitric oxide synthase
AU - Jing, Qing
AU - Li, Huiying
AU - Roman, Linda J.
AU - Martásek, Pavel
AU - Poulos, Thomas L.
AU - Silverman, Richard B.
N1 - Funding Information:
The authors are grateful for financial support from the National Institutes of Health ( GM049725 to R.B.S. and GM057353 to T.L.P.). We thank Dr. Bettie Sue Siler Masters ( NIH grant GM52419 , with whose laboratory P.M. and L.J.R. are affiliated). B.S.S.M. also acknowledges the Welch Foundation for a Robert A. Welch Distinguished Professorship in Chemistry (AQ0012). P.M. is supported by grants 0021620849 from MSMT of the Czech Republic. We also thank the beamline staff at SSRL and ALS for their assistance during the remote X-ray diffraction data collections.
Publisher Copyright:
© 2014 Elsevier Ltd. All rights reserved.
PY - 2014/9/15
Y1 - 2014/9/15
N2 - To develop potent and selective nNOS inhibitors, a new series of double-headed molecules with chiral linkers that derive from natural amino acid derivatives have been designed and synthesized. The new structures integrate a thiophenecarboximidamide head with two types of chiral linkers, presenting easy synthesis and good inhibitory properties. Inhibitor (S)-9b exhibits a potency of 14.7 nM against nNOS and is 1134 and 322-fold more selective for nNOS over eNOS and iNOS, respectively. Crystal structures show that the additional binding between the aminomethyl moiety of 9b and propionate A on the heme and tetrahydrobiopterin (H4B) in nNOS, but not eNOS, contributes to its high selectivity. This work demonstrates the advantage of integrating known structures into structure optimization, and it should be possible to more readily develop compounds that incorporate bioavailability with these advanced features. Moreover, this integrative strategy is a general approach in new drug discovery.
AB - To develop potent and selective nNOS inhibitors, a new series of double-headed molecules with chiral linkers that derive from natural amino acid derivatives have been designed and synthesized. The new structures integrate a thiophenecarboximidamide head with two types of chiral linkers, presenting easy synthesis and good inhibitory properties. Inhibitor (S)-9b exhibits a potency of 14.7 nM against nNOS and is 1134 and 322-fold more selective for nNOS over eNOS and iNOS, respectively. Crystal structures show that the additional binding between the aminomethyl moiety of 9b and propionate A on the heme and tetrahydrobiopterin (H4B) in nNOS, but not eNOS, contributes to its high selectivity. This work demonstrates the advantage of integrating known structures into structure optimization, and it should be possible to more readily develop compounds that incorporate bioavailability with these advanced features. Moreover, this integrative strategy is a general approach in new drug discovery.
KW - Heme
KW - Nitric oxide synthase
KW - Protein crystallography
KW - Selective inhibition
KW - Tetrahydrobiopterin
KW - Thiophenecarboximidamide
UR - http://www.scopus.com/inward/record.url?scp=84906964907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84906964907&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2014.07.079
DO - 10.1016/j.bmcl.2014.07.079
M3 - Article
C2 - 25149509
AN - SCOPUS:84906964907
SN - 0960-894X
VL - 24
SP - 4504
EP - 4510
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 18
ER -